Cadia Private Client LLC

SEC CIK: 0002135817
Latest filing: Aug 11, 2026

SEC filings (opens in a new tab)

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Cadia Private Client LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overview All 13F holders of HALO Full Q2 2026 holdings

Shares (Q2 2026): 21,500
Value: $1.68M
% of portfolio: 1.2%
Quarters held: 3; Since Q4 2025

Holdings of HALO by Cadia Private Client LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	21,500	$1.68M	1.2%	00.0%	Unchanged	Holders
Q1 2026	21,500	$1.39M	1.1%	00.0%	Unchanged	Holders
Q4 2025	21,500	$1.45M	1.1%	–	No prior filing	Holders